Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Director's Dealing 2019

Nov 26, 2019

64741_rns_2019-11-26_04aa2bc6-bc66-448e-965d-e9bd38194dd9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Cyclopharm Limited
ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Vanda Gould
Date of last notice 3 April 2019
Date that director ceased to be director 27 November 2019

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest
Note: Provide details of the circumstances giving rise to the relevant interest
French Park Investments Pty Ltd (director)
French Park Investments Pty Ltd (Shean Family
Super Fund A/c) (director)
Mrs Debbie Anne Gould (spouse)
Leagou Pty Limited (director)
Malackey Holdings Pty Ltd (alternate director)
Melbourne Corp of Australia Pty Ltd (director)
Melbourne Corporation of Australia Pty Ltd
(Superannuation Fund A/c) (director)
South Seas Holdings Pty Limited (director)
Chemical Trustee Limited (related party)
Note (
) : On 25 November 2016, Mr Gould notified the
market that despite the fact that he believed he did not have
the requisite control to constitute relevant interests in
Chemical Trustee Limited, as an advisor to this entity, he had
declared a relevant interest in those shares.
Number & class of securities
69,660
180,000
6,000
6,000
720,220
400,000
1,027,376
675,000
9,176,470
Total shares 12,260,726

Part 3 – Director’s interests in contracts

Detail of contract Nil
Nature of interest Nil
Name of registered holder
(if issued securities)
Nil
No. and class of securities to which
interest relates
Nil
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002